JP2015078230A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015078230A5 JP2015078230A5 JP2015006124A JP2015006124A JP2015078230A5 JP 2015078230 A5 JP2015078230 A5 JP 2015078230A5 JP 2015006124 A JP2015006124 A JP 2015006124A JP 2015006124 A JP2015006124 A JP 2015006124A JP 2015078230 A5 JP2015078230 A5 JP 2015078230A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- following formula
- acceptable salt
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000007909 solid dosage form Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
Claims (7)
- 下記式：
の化合物、またはその薬学的に許容される塩。
- 下記式：
の化合物であるか、またはその薬学的に許容される塩である、請求項１記載の化合物。 - 下記式：
の化合物、またはその薬学的に許容される塩。 - 下記式：
の化合物であるか、またはその薬学的に許容される塩である、請求項３記載の化合物。 - 有効量の請求項１〜４のいずれか一項記載の化合物と、薬学的に許容される担体とを含む、薬学的組成物。
- 固体の剤形として製剤化される、請求項５記載の薬学的組成物。
- カプセル剤、錠剤、エアゾール、液剤、または懸濁剤として製剤化されるか、または局所製剤もしくは溶液である、請求項５記載の薬学的組成物。
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16881399P | 1999-12-03 | 1999-12-03 | |
| US60/168,813 | 1999-12-03 | ||
| US20571900P | 2000-05-19 | 2000-05-19 | |
| US60/205,719 | 2000-05-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011153911A Division JP2011246475A (ja) | 1999-12-03 | 2011-07-12 | ホスホネート化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015078230A JP2015078230A (ja) | 2015-04-23 |
| JP2015078230A5 true JP2015078230A5 (ja) | 2015-12-24 |
| JP5963894B2 JP5963894B2 (ja) | 2016-08-03 |
Family
ID=26864475
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541459A Expired - Lifetime JP4993649B2 (ja) | 1999-12-03 | 2000-12-04 | ホスホネート化合物 |
| JP2011153911A Withdrawn JP2011246475A (ja) | 1999-12-03 | 2011-07-12 | ホスホネート化合物 |
| JP2014002881A Expired - Lifetime JP5963787B2 (ja) | 1999-12-03 | 2014-01-10 | ホスホネート化合物 |
| JP2015006124A Expired - Lifetime JP5963894B2 (ja) | 1999-12-03 | 2015-01-15 | ホスホネート化合物 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541459A Expired - Lifetime JP4993649B2 (ja) | 1999-12-03 | 2000-12-04 | ホスホネート化合物 |
| JP2011153911A Withdrawn JP2011246475A (ja) | 1999-12-03 | 2011-07-12 | ホスホネート化合物 |
| JP2014002881A Expired - Lifetime JP5963787B2 (ja) | 1999-12-03 | 2014-01-10 | ホスホネート化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (14) | US6716825B2 (ja) |
| EP (1) | EP1233770B1 (ja) |
| JP (4) | JP4993649B2 (ja) |
| KR (1) | KR20020073342A (ja) |
| CN (1) | CN1414854B (ja) |
| AT (1) | ATE385797T1 (ja) |
| AU (3) | AU785355B2 (ja) |
| BR (1) | BR0016058A (ja) |
| CA (2) | CA2393410C (ja) |
| CY (1) | CY1107927T1 (ja) |
| DE (1) | DE60038038T2 (ja) |
| DK (2) | DK1914237T3 (ja) |
| ES (2) | ES2300281T3 (ja) |
| HK (1) | HK1050627B (ja) |
| MX (1) | MXPA02005490A (ja) |
| PT (2) | PT1233770E (ja) |
| RU (1) | RU2258707C2 (ja) |
| WO (1) | WO2001039724A2 (ja) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7205404B1 (en) | 1999-03-05 | 2007-04-17 | Metabasis Therapeutics, Inc. | Phosphorus-containing prodrugs |
| KR20020073342A (ko) * | 1999-12-03 | 2002-09-23 | 더 리젠트 오브 더 유니버시티 오브 캘리포니아, 샌디에고 | 포스포네이트 화합물 |
| US7163932B2 (en) * | 2001-06-20 | 2007-01-16 | Merck Frosst Canada & Co. | Aryldifluoromethylphosphonic acids for treatment of diabetes |
| DE60235085D1 (de) * | 2001-07-16 | 2010-03-04 | Univ Paris Xiii | Herstellungsverfahren von derivate von bisphosphonaten |
| FR2837490B1 (fr) * | 2002-03-21 | 2009-04-17 | Univ Paris 13 | Nouveaux derives de bisphosphonates, leurs preparations et utilisations |
| ES2448501T3 (es) * | 2002-03-06 | 2014-03-14 | Effrx Pharmaceuticals Sa | Composiciones efervescentes que comprenden bisfosfonatos |
| US7488496B2 (en) | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
| WO2003091264A2 (en) * | 2002-04-26 | 2003-11-06 | Gilead Sciences, Inc. | Non nucleoside reverse transcriptase inhibitors |
| AU2003901813A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Pharmaceutical derivatives |
| EA200501676A1 (ru) | 2003-04-25 | 2006-04-28 | Джилид Сайэнс, Инк. | Фосфонатсодержащие ингибиторы киназы (варианты), способ их получения, фармацевтическая композиция, лекарственная форма на их основе и способ ингибирования киназы у млекопитающего (варианты) |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| WO2005002626A2 (en) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
| WO2004096287A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| ATE490788T1 (de) | 2003-04-25 | 2010-12-15 | Gilead Sciences Inc | Antivirale phosphonate analoge |
| WO2004096285A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Anti-infective phosphonate conjugates |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| WO2005044279A1 (en) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Purine nucleoside phosphonate conjugates |
| WO2005044308A1 (en) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| EP1678322A2 (en) | 2003-10-24 | 2006-07-12 | Gilead Sciences, Inc. | Methods and compositions for identifying therapeutic compounds |
| WO2005056019A1 (ja) * | 2003-12-12 | 2005-06-23 | Astellas Pharma Inc. | 悪性黒色腫治療剤 |
| JP2007515495A (ja) | 2003-12-22 | 2007-06-14 | ギリアード サイエンシーズ， インコーポレイテッド | ４’−置換カルボビル誘導体およびアバカビル誘導体ならびにｈｉｖおよびｈｃｖ抗ウイルス活性を有する関連化合物 |
| WO2005090370A1 (en) * | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| WO2006076015A2 (en) * | 2004-04-30 | 2006-07-20 | The Regents Of The University Of California | 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof |
| EP1778251B1 (en) | 2004-07-27 | 2011-04-13 | Gilead Sciences, Inc. | Nucleoside phosphonate conjugates as anti hiv agents |
| WO2006055525A2 (en) * | 2004-11-15 | 2006-05-26 | Ceptyr, Inc. | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| WO2006066074A2 (en) | 2004-12-16 | 2006-06-22 | The Regents Of The University Of California | Lung-targeted drugs |
| US8071574B2 (en) * | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
| US20060219637A1 (en) * | 2005-03-29 | 2006-10-05 | Killeen Kevin P | Devices, systems and methods for liquid chromatography |
| WO2006130217A2 (en) * | 2005-04-01 | 2006-12-07 | The Regents Of The University Of California | Substituted phosphate esters of nucleoside phosphonates |
| EP2842559A3 (en) | 2005-04-08 | 2015-03-18 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| EP1868628B1 (en) * | 2005-04-08 | 2014-06-11 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
| WO2006114065A2 (en) * | 2005-04-25 | 2006-11-02 | Institute Of Organic Chemistry And Biochemistry A Cademy Of Sciences Of The Czech Republic | Use of compounds to inhibit neoplasia |
| US7914810B2 (en) | 2005-05-06 | 2011-03-29 | Synthes Usa, Llc | Methods for the in situ treatment of bone cancer |
| US8114843B2 (en) | 2005-11-18 | 2012-02-14 | The Regents Of The University Of California | Photoreactive regulator of protein function and methods of use thereof |
| EP2012799B1 (en) * | 2006-05-03 | 2016-08-24 | Chimerix, Inc. | Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates |
| AU2008246195B2 (en) * | 2007-04-27 | 2014-06-05 | Emergent Biodefence Operations Lansing Llc | Methods of Reducing Nephrotoxicity in Subjects Administered with Nucleoside Phosphonates |
| JP2011508740A (ja) * | 2007-12-27 | 2011-03-17 | エピファニー バイオサイエンシズ， インク． | 抗ウイルス化合物 |
| EP2254582B1 (en) | 2008-01-25 | 2016-01-20 | Chimerix, Inc. | Methods of treating viral infections |
| AU2009268681B2 (en) | 2008-07-08 | 2014-10-02 | Gilead Sciences, Inc. | Salts of HIV inhibitor compounds |
| US8628812B2 (en) | 2008-12-30 | 2014-01-14 | Pepsico, Inc. | Preservative system for acidic beverages based on sequestrants |
| EP2270021A1 (en) * | 2009-06-18 | 2011-01-05 | Centre National de la Recherche Scientifique | Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability |
| WO2011005510A2 (en) * | 2009-06-22 | 2011-01-13 | Cerapedics, Inc. | Peptide conjugates and uses thereof |
| WO2011011519A1 (en) | 2009-07-21 | 2011-01-27 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
| EP2462152A4 (en) | 2009-08-03 | 2013-02-13 | Chimerix Inc | COMPOSITION AND METHODS FOR TREATING VIRAL INFECTIONS AND TUMORS OF VIRAL ORIGIN |
| ES2533799T3 (es) * | 2009-10-02 | 2015-04-14 | Straitmark Holding Ag | Procedimiento de fabricación de ácidos aminohidroxi difosfónicos |
| US9006218B2 (en) | 2010-02-12 | 2015-04-14 | Chimerix Inc. | Nucleoside phosphonate salts |
| AU2011239560B2 (en) | 2010-04-14 | 2016-11-03 | The Regents Of The University Of California | Phosphonates with reduced toxicity for treatment of viral infections |
| EP2563367A4 (en) | 2010-04-26 | 2013-12-04 | Chimerix Inc | METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES |
| AU2015201895B2 (en) * | 2010-08-31 | 2016-11-17 | Emergent Biodefence Operations Lansing Llc | Phosphonate ester derivatives and methods of synthesis thereof |
| ES2700117T3 (es) * | 2010-08-31 | 2019-02-14 | Chimerix Inc | Derivados de éster de fosfonato y métodos de síntesis de los mismos |
| US8884027B2 (en) | 2010-10-22 | 2014-11-11 | University Of Rochester | Melampomagnolide B derivatives as antileukemic and cytotoxic agents |
| KR20140064917A (ko) * | 2011-08-31 | 2014-05-28 | 말린크로트 엘엘씨 | H-포스포네이트-엔/-인 히드로포스포닐화 반응을 이용한 표적화된 나노입자의 원격 어셈블리 |
| ES2734495T3 (es) | 2011-12-22 | 2019-12-10 | Geron Corp | Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros |
| US20150209273A1 (en) * | 2012-08-28 | 2015-07-30 | Glaxosmithkline Llc | Pharmaceutical Compositions |
| BR112015023705A8 (pt) * | 2013-03-15 | 2020-03-17 | Univ California | compostos, composições farmacêuticas, usos de um composto, e método para síntese do composto da fórmula (ia) |
| DK2999476T3 (en) | 2013-11-15 | 2018-09-03 | Chimerix Inc | MORPHIC FORMS OF HEXADECYLOXYPROPYL PHOSPHONATE TESTERS |
| US10449210B2 (en) | 2014-02-13 | 2019-10-22 | Ligand Pharmaceuticals Inc. | Prodrug compounds and their uses |
| JP6313479B2 (ja) | 2014-03-14 | 2018-04-18 | オールテック，インク． | 有機セレン化合物の組成物およびその使用方法 |
| CN106687118A (zh) | 2014-07-02 | 2017-05-17 | 配体药物公司 | 前药化合物及其用途 |
| PL3194411T3 (pl) | 2014-09-15 | 2022-06-20 | The Regents Of The University Of California | Analogi nukleotydów |
| WO2016069630A1 (en) | 2014-10-27 | 2016-05-06 | Concert Pharmaceuticals, Inc. | Pyrimidine phosphonic acid esters bearing at least one deuterium atom |
| KR102363946B1 (ko) | 2015-03-06 | 2022-02-17 | 아테아 파마슈티컬즈, 인크. | HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드 |
| ES2951653T3 (es) * | 2015-04-27 | 2023-10-24 | Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct | Moléculas dirigidas a EGR1 para el tratamiento de afecciones inflamatorias e hiperproliferativas |
| WO2017048956A1 (en) | 2015-09-15 | 2017-03-23 | The Regents Of The University Of California | Nucleotide analogs |
| WO2017048252A1 (en) | 2015-09-15 | 2017-03-23 | Alltech, Inc. | Compositions of selenoorganic compounds and methods of use thereof |
| RU2628456C1 (ru) * | 2016-06-29 | 2017-08-17 | Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) | Новые пиримидиновые ингибиторы репликации аденовируса человека |
| WO2018013937A1 (en) | 2016-07-14 | 2018-01-18 | Atea Pharmaceuticals, Inc. | Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
| KR20190043602A (ko) | 2016-09-07 | 2019-04-26 | 아테아 파마슈티컬즈, 인크. | Rna 바이러스 치료를 위한 2'-치환된-n6-치환된 퓨린 뉴클레오티드 |
| EP3960740B1 (en) | 2017-08-01 | 2023-11-15 | Gilead Sciences, Inc. | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) vanillate for treating viral infections |
| RU2670204C1 (ru) * | 2017-12-01 | 2018-10-19 | федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Производные 2-тиоурацила, обладающие противоаденовирусной активностью |
| EP3730503A4 (en) * | 2017-12-21 | 2021-05-05 | Shenzhen TargetRx, Inc. | ANTIVIRAL REVERSE TRANSCRIPTASE INHIBITOR |
| AU2019207625A1 (en) | 2018-01-09 | 2020-07-30 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| WO2021173713A1 (en) | 2020-02-27 | 2021-09-02 | Atea Pharmaceuticals, Inc. | Highly active compounds against covid-19 |
| BR112023002951A2 (pt) | 2020-08-24 | 2023-03-21 | Gilead Sciences Inc | Compostos de fosfolipídio e usos destes |
| TWI811812B (zh) | 2020-10-16 | 2023-08-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1944530A (en) | 1929-04-08 | 1934-01-23 | Ig Farbenindustrie Ag | Phosphoric acid esters |
| DE2009341C3 (de) * | 1970-02-27 | 1979-06-21 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | 3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung |
| US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
| FR2586685B1 (fr) * | 1985-09-03 | 1987-12-11 | Protex Manuf Prod Chimiq | Procede de preparation de nouveaux agents dispersants cationiques |
| FI83421C (fi) * | 1989-06-21 | 1991-07-10 | Huhtamaeki Oy | Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat. |
| US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
| DE10399025I2 (de) * | 1990-09-14 | 2007-11-08 | Acad Of Science Czech Republic | Wirkstoffvorläufer von Phosphonaten |
| EP0477454A1 (en) * | 1990-09-28 | 1992-04-01 | Merrell Dow Pharmaceuticals Inc. | Novel phosphonate derivatives of certain nucleosides |
| US5672697A (en) * | 1991-02-08 | 1997-09-30 | Gilead Sciences, Inc. | Nucleoside 5'-methylene phosphonates |
| JPH05339280A (ja) * | 1991-04-26 | 1993-12-21 | Japan Tobacco Inc | （ｎ−二環置換）アミノメチレンビスフォスフォン酸誘導体 |
| JP3341303B2 (ja) * | 1991-07-11 | 2002-11-05 | 東レ株式会社 | メチレンジホスホン酸誘導体、その製造方法およびその医薬用途 |
| US5879700A (en) | 1991-10-15 | 1999-03-09 | Hostetler; Karl Y. | Nucleoside analogue phosphates for topical use |
| US5618804A (en) | 1992-07-10 | 1997-04-08 | Toray Industries, Inc. | Methanediphosphonic acid derivative, process for production thereof and use for pharmaceuticals |
| CA2126601A1 (en) | 1993-06-29 | 1994-12-30 | Mitsubishi Chemical Corporation | Phosphonate-nucleotide ester derivatives |
| JP3580377B2 (ja) * | 1993-06-29 | 2004-10-20 | 三菱化学株式会社 | ホスホナートヌクレオチドエステル誘導体 |
| US5627185A (en) * | 1994-11-23 | 1997-05-06 | Gosselin; Gilles | Acyclovir derivatives as antiviral agents |
| CH690163A5 (fr) | 1995-07-28 | 2000-05-31 | Symphar Sa | Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers. |
| US5922695A (en) * | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
| JP3889449B2 (ja) * | 1996-12-19 | 2007-03-07 | 花王株式会社 | 歯のコーティング剤組成物 |
| US6686462B2 (en) * | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
| NZ550116A (en) | 1997-08-18 | 2008-03-28 | Neurochem Int Ltd | Phosphono-carboxylate compounds for treating amyloidosis |
| FR2781228B1 (fr) * | 1998-07-16 | 2000-09-29 | Pf Medicament | Phosphonates insatures derives d'indole |
| KR20020073342A (ko) * | 1999-12-03 | 2002-09-23 | 더 리젠트 오브 더 유니버시티 오브 캘리포니아, 샌디에고 | 포스포네이트 화합물 |
-
2000
- 2000-12-04 KR KR1020027007074A patent/KR20020073342A/ko not_active Application Discontinuation
- 2000-12-04 CA CA2393410A patent/CA2393410C/en not_active Expired - Lifetime
- 2000-12-04 WO PCT/US2000/033079 patent/WO2001039724A2/en active IP Right Grant
- 2000-12-04 RU RU2002118327/04A patent/RU2258707C2/ru active
- 2000-12-04 MX MXPA02005490A patent/MXPA02005490A/es active IP Right Grant
- 2000-12-04 CA CA2747954A patent/CA2747954C/en not_active Expired - Lifetime
- 2000-12-04 DK DK08001408.7T patent/DK1914237T3/da active
- 2000-12-04 ES ES00982468T patent/ES2300281T3/es not_active Expired - Lifetime
- 2000-12-04 PT PT00982468T patent/PT1233770E/pt unknown
- 2000-12-04 ES ES08001408.7T patent/ES2498046T3/es not_active Expired - Lifetime
- 2000-12-04 EP EP00982468A patent/EP1233770B1/en not_active Expired - Lifetime
- 2000-12-04 DK DK00982468T patent/DK1233770T3/da active
- 2000-12-04 DE DE60038038T patent/DE60038038T2/de not_active Expired - Lifetime
- 2000-12-04 JP JP2001541459A patent/JP4993649B2/ja not_active Expired - Lifetime
- 2000-12-04 AU AU19497/01A patent/AU785355B2/en not_active Ceased
- 2000-12-04 BR BR0016058-0A patent/BR0016058A/pt not_active Application Discontinuation
- 2000-12-04 PT PT80014087T patent/PT1914237E/pt unknown
- 2000-12-04 CN CN00818111.XA patent/CN1414854B/zh not_active Expired - Lifetime
- 2000-12-04 US US10/148,374 patent/US6716825B2/en not_active Expired - Lifetime
- 2000-12-04 AT AT00982468T patent/ATE385797T1/de active
-
2003
- 2003-02-27 HK HK03101480.2A patent/HK1050627B/zh not_active IP Right Cessation
-
2004
- 2004-01-15 US US10/759,345 patent/US7034014B2/en not_active Expired - Lifetime
-
2005
- 2005-04-06 US US11/101,259 patent/US7098197B2/en not_active Expired - Lifetime
- 2005-04-06 US US11/100,882 patent/US7094772B2/en not_active Expired - Lifetime
-
2006
- 2006-08-17 US US11/506,292 patent/US7452898B2/en not_active Expired - Lifetime
- 2006-12-15 AU AU2006252074A patent/AU2006252074B2/en not_active Ceased
-
2007
- 2007-03-07 US US11/715,604 patent/US7790703B2/en not_active Expired - Fee Related
- 2007-10-26 US US11/925,309 patent/US7687480B2/en not_active Expired - Fee Related
-
2008
- 2008-04-30 CY CY20081100465T patent/CY1107927T1/el unknown
-
2010
- 2010-02-05 US US12/701,410 patent/US8008308B2/en not_active Expired - Fee Related
- 2010-12-20 AU AU2010257309A patent/AU2010257309B2/en not_active Ceased
-
2011
- 2011-07-12 JP JP2011153911A patent/JP2011246475A/ja not_active Withdrawn
- 2011-08-29 US US13/220,548 patent/US8309565B2/en not_active Expired - Lifetime
-
2012
- 2012-10-04 US US13/645,105 patent/US8710030B2/en not_active Expired - Fee Related
-
2013
- 2013-10-21 US US14/059,365 patent/US8889658B2/en not_active Expired - Fee Related
-
2014
- 2014-01-10 JP JP2014002881A patent/JP5963787B2/ja not_active Expired - Lifetime
- 2014-10-29 US US14/527,156 patent/US9206208B2/en not_active Expired - Fee Related
-
2015
- 2015-01-15 JP JP2015006124A patent/JP5963894B2/ja not_active Expired - Lifetime
- 2015-11-16 US US14/942,926 patent/US9649321B2/en not_active Expired - Lifetime
-
2017
- 2017-05-15 US US15/595,496 patent/US10071110B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015078230A5 (ja) | ||
| JP2014221779A5 (ja) | ||
| JP2014507446A5 (ja) | ||
| JP2019048894A5 (ja) | ||
| JP2017105793A5 (ja) | ||
| JP2013032389A5 (ja) | ||
| JP2017509667A5 (ja) | ||
| JP2017537066A5 (ja) | ||
| JP2013014622A5 (ja) | ||
| JP2016518337A5 (ja) | ||
| CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| JP2013518107A5 (ja) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| JP2014218522A5 (ja) | ||
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| JP2017517565A5 (ja) | ||
| JP2011527299A5 (ja) | ||
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| JP2015516419A5 (ja) | ||
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
| PH12015501945B1 (en) | Formulations of organic compounds | |
| JP2016532632A5 (ja) | ||
| JP2016515550A5 (ja) |